Karyopharm Therapeutics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KPTI and other ETFs, options, and stocks.

About KPTI

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. Its Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and inhibiting the nuclear export protein XPO1 (or CRM1).

CEO

Richard A. Paulson

CEORichard A. Paulson

Employees

442

Employees442

Headquarters

Newton, Massachusetts

HeadquartersNewton, Massachusetts

Founded

2008

Founded2008

Employees

442

Employees442

KPTI Key Statistics

Market cap

401.72M

Market cap401.72M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.46M

Average volume1.46M

High today

$4.96

High today$4.96

Low today

$4.80

Low today$4.80

Open price

$4.89

Open price$4.89

Volume

403.36K

Volume403.36K

52 Week high

$14.73

52 Week high$14.73

52 Week low

$4.00

52 Week low$4.00

Analyst ratings

56%

of 9 ratings

Buy

44.4%

Hold

55.6%

Sell

KPTI Earnings

-$0.77

-$0.36

$0.05

$0.46

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Feb 7, After Hours

ActualExpected Feb 7, After Hours